IDEA #7VMEYQ Nitric oxide and hydrogen sulfide releasing hybrids as anti-inflammatory agents and uses thereof. 12A0004

The invention is directed to compounds and compositions that can be used to treat any inflammatory-based diseases, in particular cancer. Other diseases that have chronic inflammation as an underlying cause include, rheumatoid arthritis, atherosclerosis and other cardiovascular diseases, Alzheimer’s and other neurodegenerative diseases.
For more information or to license this innovation: